Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Concord Drugs Ltd
Concord Drugs Ltd

Concord Drugs Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 861
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹75.50
₹-1.80 (-2.33%)
75.15Low
Today’s Performance
77.99High
26.10Low
52 Week’s Performance
92.52High

bt_logoStock Performance

  • 1 Day-2.33%
  • 1 Week-9.43%
  • 1 Month1.78%
  • 3 Months15.71%
  • 6 Months131.10%
  • 1 Year98.63%
  • 3 Years30.53%
  • 5 Years26.08%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.35
  • 52-Week Low (₹)26.10
  • 52-Week High (₹)92.52
  • Price-to-Book (X)*2.19
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*130.17
  • Earnings Per Share (₹)0.58
  • Market Cap (₹ Cr.)*75.50
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
View more

bt_logoFAQ's

What was Concord Drugs Ltd share price previously?
Concord Drugs Ltd share price was down by -2.33% from the previous closing price of ₹77.30.
Who are peers of Concord Drugs Ltd?
The peers of Concord Drugs Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Concord Drugs Ltd?
The promotor/promotors of Concord Drugs Ltd are S Nagi Reddy, K Ramchandra Reddy, Koni Reddy, S. Nagavenkata Hareesh, S. Manoj Kumar Reddy, Summela Kasu, Namratha Nagla.
What has been 52-week high of Concord Drugs Ltd stocks?
The highest price of Concord Drugs Ltd stock is ₹92.52 in the last 52-week.
What is the share price of Concord Drugs Ltd (CONCORD) today on BSE?
As on Dec 05, 2025 Concord Drugs Ltd (CONCORD)’s share price on BSE is Rs 75.5
What is the market cap of Concord Drugs Ltd (CONCORD)?
The current market capitalisation of Concord Drugs Ltd (CONCORD) is 75.50 crores
What is Concord Drugs Ltd Share symbol?
The symbol of Concord Drugs Ltd is .
What is the PE ratio of Concord Drugs Ltd (CONCORD)?
The current PE ratio of Concord Drugs Ltd (CONCORD) is 130.17.
What is the PB ratio of Concord Drugs Ltd (CONCORD)?
The current PB ratio of Concord Drugs Ltd (CONCORD) is 2.19.
Today’s High & Low share prices of Concord Drugs Ltd (CONCORD) on BSE?
Today, the share price of Concord Drugs Ltd (CONCORD) on BSE touched a high of Rs 77.99 and a low of Rs 75.15
What price did Concord Drugs Ltd (CONCORD) shares open on the BSE today?
On BSE, the share price of Concord Drugs Ltd (CONCORD) opened at Rs 77.99
What is the 52-week high of Concord Drugs Ltd (CONCORD)?
The 52-week high price of Concord Drugs Ltd (CONCORD) is Rs 92.52
What is the 52-week low of Concord Drugs Ltd (CONCORD)?
The 52-week low price of Concord Drugs Ltd (CONCORD) is Rs 26.10

bt_logoAbout Concord Drugs

Concord Drugs Ltd, incorporated in the year 1995, has its registered office in Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511, 91-40-24036379. The main industry in which Concord Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Concord Drugs Ltd is/are Pundarikashyam and Associates. In the main management, S Nagi Reddy is chairman and Namratha Nagla is the company secretary for Concord Drugs Ltd.

  • SNR
    S Nagi ReddyChairman & Managing Director
  • KRR
    K Ramchandra ReddyIndependent Director
  • KR
    Koni ReddyWhole Time Director & Chief Financial Officer
  • SNH
    S. Nagavenkata HareeshIndependent Director
  • SMKR
    S. Manoj Kumar ReddyWhole-time Director
  • SK
    Summela KasuIndependent Director
  • NN
    Namratha NaglaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.